Billionaire Israel 'Izzy' Englander Increases Stake in AbbVie and Invests in SpaceX
Israel 'Izzy' Englander, founder of the Millennium Management hedge fund, has significantly increased his stake in pharmaceutical company AbbVie by over 100%, acquiring an additional 840,718 shares to bring his total position to around $380 million. He also initiated a new investment in SpaceX with nearly $3 billion worth of stock. The move into SpaceX is seen as somewhat expected due to the company's growth potential and strong Q2 revenue performance. AbbVie’s appeal lies partly in its robust dividend yield, currently at 2.7%, which has been growing steadily over time. However, concerns about AbbVie's valuation persist; its price-to-sales ratio is higher than previous levels but still relatively modest compared to SpaceX. The pharmaceutical giant also recently acquired Apogee Therapeutics for $11 billion, raising questions about long-term debt implications. From a market perspective, Englander’s moves reflect confidence in both the healthcare and space sectors. His investments may signal broader trends or strategic bets on companies with strong fundamentals despite valuation concerns.
Topics: AbbVie Israel Englander Millennium Management SpaceX Stock Purchases